Metabolites as immunomodulatory additives for biomaterials
The biomaterials are crucial for the surgical remediation of bone defects caused by various diseases e.g. osteoporosis and traumatic fractures. However, there are several risks associated with this treatment; first, the surgical p...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MACxercise
Dissecting Macrophage Mechanobiology to Engineer Immuno-Rege...
1M€
Cerrado
ImmunoBioSynth
Synergistic engineering of anti tumor immunity by synthetic...
2M€
Cerrado
IMMODGEL
Local Immunomodulation around implants by innovative auxilia...
7M€
Cerrado
PID2020-119333RB-I00
SOPORTES BIOFUNCIONALES CON CAPACIDAD OSTEOINDUCTORA Y ANTIM...
79K€
Cerrado
BES-2010-032200
BIOMATERIALES CON PROPIEDADES ANTIMICROBIANAS Y DE REGENERAC...
43K€
Cerrado
VASCUBONE
Construction kit for tailor made vascularized boneimplants
16M€
Cerrado
Información proyecto Met4Bone
Duración del proyecto: 27 meses
Fecha Inicio: 2020-04-28
Fecha Fin: 2022-07-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The biomaterials are crucial for the surgical remediation of bone defects caused by various diseases e.g. osteoporosis and traumatic fractures. However, there are several risks associated with this treatment; first, the surgical procedure itself carries a potential risk of inflammation and bone infection, second, the bone replacement can fail requiring revision surgery. In fact, the host immune response to implanted materials and devices is the main factor that will determine a long-term functional outcome of the biomaterial mediated treatment. Therefore, the bone biomaterial ability to modulate the local immune environment for favorable treatment outcomes has to be considered. The usage of bioactive metabolites has emerged as one of the most novel and potent approach for immune response modulation. The incorporation of metabolites with immune regulatory properties seems an especially attractive option for biomaterials as it would ensure site-specific delivery system and allow modulation of the microenvironment. The goal of this project is to develop novel biomaterials with incorporated metabolites as a potentially effective and safe strategy to modulate local immune response towards favorable outcomes of surgical bone remediation. To achieve it, the recent concept of metabolomics with the state of the art biomaterial design and research will be combined in this project. This proposal includes the transfer of knowledge to the host institution and the training of the researcher in new techniques and skills. The multidisciplinary nature of the project is strong, combining materials science, biochemistry, and molecular biology. Results have the potential to pave the way for novel biomaterials significantly improving clinical outcomes for patients suffering from bone injuries.